KraneShares China Alpha Index ETF (KCAI)
Live price chart, market sentiment, and community perspectives for KraneShares China Alpha Index ETF (AMEX: KCAI).
Live price chart, market sentiment, and community perspectives for KraneShares China Alpha Index ETF (AMEX: KCAI).
On our desk, KCAI looks more like a proof-of-concept vehicle than a liquid trading instrument. With a market cap hovering around $3.27 million and average daily volume frequently sitting near 1,000 shares, execution risk is front and center. However, the macro thesis is intriguing: you get a long-only CSI 300 universe filtered through Quant Insight's machine learning model, capitalizing on A-Shares' low correlation of under 0.4 to global benchmarks. If you are exploring dynamic, AI-driven asset allocation into structurally underrepresented Chinese equities, the strategy is clever, but position sizing must account for the micro-cap liquidity profile.
Watching the moving averages around $32.00 to $32.22, the price action for KCAI has stayed remarkably range-bound. Recent reports show short interest ticked up by roughly 49.8% heading into late summer, though in absolute terms, it represents just 1,074 shares shorted with a days-to-cover ratio around 1.0 days. This indicates that while short sellers are noticing the vehicle, absolute short exposure is negligible due to the overall low float and limited institutional sponsorship—only about 2 to 4 institutional entities filing 13F/13G forms with small allocations.
From a quantitative implementation perspective, KCAI's reliance on Qi's alpha optimization filtering process is worth studying. The fund rebalances monthly using proprietary AI investment decision-making technology while capping individual stock weightings at 5% for diversification. For researchers building rules-based systematic strategies in emerging markets, watching how this monthly AI rotation handles the low global correlation of China A-Shares offers a practical benchmark for machine learning alpha generation in restricted access zones.
Explore plasma cleansing, somatic organ swaps, and BCI.